Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BH4 Increases nNOS Activity and Preserves Left Ventricular Function in Diabetes.

Journal article

Carnicer Hijazo R. et al, (2021), Circulation research

BH4 SUPPLEMENTATION AS A NEW TREATMENT FOR DIABETIC CARDIOMYOPATHY

Conference paper

Carnicer R. et al, (2019), HEART, 105, A153 - A153

Fast, quantitative, murine cardiac 19F MRI/MRS of PFCE-labeled progenitor stem cells and macrophages at 9.4T

Journal article

Constantinides C. et al, (2018), PLoS ONE, 13, e0190558 - e0190558

Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase.

Journal article

Reilly SN. et al, (2017), Science translational medicine, 8, 340ra74 - 340ra74

Protein inhibitor of NOS1 plays a central role in the regulation of myocardial Ca2+ homeostasis in human heart failure

Conference paper

Rosello-Lleti E. et al, (2016), EUROPEAN HEART JOURNAL, 37, 912 - 912

Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation

Conference paper

Ziberna K. et al, (2016), DIABETOLOGIA, 59, S12 - S12

Human Ischemic Cardiomyopathy Shows Cardiac Nos1 Translocation and its Increased Levels are Related to Left Ventricular Performance.

Journal article

Roselló-Lletí E. et al, (2016), Scientific reports, 6, 24060 - 24060

The role of nitric oxide synthase (NOS) and its essential cofactor tetrahydrobiopterin (BH4) in diabetic cardiomyopathy

Conference paper

Duglan D. et al, (2015), EUROPEAN HEART JOURNAL, 36, 775 - 775

Load More